LON:AZN - AstraZeneca Share Price, Forecast & News

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

AstraZeneca declared a dividend on Thursday, July 25th. Shareholders of record on Thursday, August 8th will be paid a dividend of GBX 71.90 per share on Monday, September 9th. This represents a yield of 1.07%. The ex-dividend date of this dividend is Thursday, August 8th. The official announcement can be seen at this link. View AstraZeneca's Dividend History.

AstraZeneca is scheduled to release their next quarterly earnings announcement on Friday, February 14th 2020. View Earnings Estimates for AstraZeneca.

16 equities research analysts have issued 12-month target prices for AstraZeneca's shares. Their forecasts range from GBX 5,500 to £100. On average, they anticipate AstraZeneca's share price to reach GBX 7,831.07 in the next year. This suggests that the stock has a possible downside of 0.6%. View Analyst Price Targets for AstraZeneca.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 3 sell ratings, 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AstraZeneca.

Media headlines about AZN stock have trended positive on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. AstraZeneca earned a news sentiment score of 2.2 on InfoTrie's scale. They also assigned news stories about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for AstraZeneca.

Some companies that are related to AstraZeneca include GlaxoSmithKline (GSK), Bayer (BAYN), Hutchison China MediTech (HCM), Dechra Pharmaceuticals (DPH), Opthea (OPT), Mayne Pharma Group (MYX), Medical Developments International (MVP), Vectura Group (VEC), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Pharmaxis (PXS), Recce Pharmaceuticals (RCE) and Vita Life Sciences (VLS).

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), Hain Celestial Group (HAIN), Vodafone Group (VOD), NVIDIA (NVDA), National Retail Properties (NNN), BP (BP), Royal Dutch Shell (RDSB), Marks and Spencer Group (MKS), Encana (ECA) and Philip Morris International (PM).

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of AZN stock can currently be purchased for approximately GBX 7,878.

AstraZeneca has a market capitalization of £103.37 billion and generates £24.14 billion in revenue each year. AstraZeneca employs 64,400 workers across the globe.View Additional Information About AstraZeneca.

The official website for AstraZeneca is http://www.astrazeneca.com/.

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.